Literature DB >> 2478589

Hepatocellular copper toxicity and its attenuation by zinc.

M L Schilsky1, R R Blank, M J Czaja, M A Zern, I H Scheinberg, R J Stockert, I Sternlieb.   

Abstract

We studied the mechanisms by which excess copper exerts, and zinc mitigates, toxic effects on HepG2 cells. Survival and cell growth were reduced in media containing greater than 500 microM copper chloride for 48 h; LD50 was 750 microM. At 1,000 microM copper for 1 h, there was a general reduction of protein synthesis, and no recognizable changes in cellular ultrastructure. Incubation of cells with 200 microM zinc acetate before exposure to copper, raised the LD50 for confluent cells to 1,250 microM copper chloride, improved protein synthesis, and increased synthesis of a 10-kD protein, apparently metallothionein. The mitigation, by zinc, of copper's toxicity may in part be mediated through induction of this protein in the hepatocyte.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2478589      PMCID: PMC304022          DOI: 10.1172/JCI114333

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

1.  CYTOTOXIC TEST FOR DEMONSTRATION OF MOUSE ANTIBODY.

Authors:  E A BOYSE; L J OLD; I CHOUROULINKOV
Journal:  Methods Med Res       Date:  1964

Review 2.  Copper and the liver.

Authors:  I Sternlieb
Journal:  Gastroenterology       Date:  1980-06       Impact factor: 22.682

3.  Chromosomal location of human metallothionein genes: implications for Menkes' disease.

Authors:  C J Schmidt; D H Hamer; O W McBride
Journal:  Science       Date:  1984-06-08       Impact factor: 47.728

Review 4.  Absorption, transport, and hepatic metabolism of copper and zinc: special reference to metallothionein and ceruloplasmin.

Authors:  R J Cousins
Journal:  Physiol Rev       Date:  1985-04       Impact factor: 37.312

5.  The sequence of human serum albumin cDNA and its expression in E. coli.

Authors:  R M Lawn; J Adelman; S C Bock; A E Franke; C M Houck; R C Najarian; P H Seeburg; K L Wion
Journal:  Nucleic Acids Res       Date:  1981-11-25       Impact factor: 16.971

6.  Increased type I procollagen mRNA levels and in vitro protein synthesis in the baboon model of chronic alcoholic liver disease.

Authors:  M A Zern; M A Leo; M A Giambrone; C S Lieber
Journal:  Gastroenterology       Date:  1985-11       Impact factor: 22.682

7.  Induction of metallothionein-I mRNA in cultured cells by heavy metals and iodoacetate: evidence for gratuitous inducers.

Authors:  D M Durnam; R D Palmiter
Journal:  Mol Cell Biol       Date:  1984-03       Impact factor: 4.272

8.  Immunohistochemical demonstration of the cytoplasmic copper-associated protein in the liver in primary biliary cirrhosis: its identification as metallothionein.

Authors:  A R Janssens; F T Bosman; D J Ruiter; C J Van den Hamer
Journal:  Liver       Date:  1984-04

9.  Hepatic lysosomal copper protein in dogs with an inherited copper toxicosis.

Authors:  G F Johnson; A G Morell; R J Stockert; I Sternlieb
Journal:  Hepatology       Date:  1981 May-Jun       Impact factor: 17.425

10.  Electron probe X-ray analysis on human hepatocellular lysosomes with copper deposits: copper binding to a thiol-protein in lysosomes.

Authors:  T Hanaichi; R Kidokoro; H Hayashi; N Sakamoto
Journal:  Lab Invest       Date:  1984-11       Impact factor: 5.662

View more
  19 in total

1.  Wilson's Disease.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1999-02

2.  Zinc uptake and storage: the role of fundus pigmentation.

Authors:  Despina Kokkinou; Haino Uwe Kasper; Tobias Schwarz; Karl Ulrich Bartz-Schmidt; Ulrich Schraermeyer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-10-20       Impact factor: 3.117

Review 3.  Current anti-copper therapies in management of Wilson disease.

Authors:  Isabelle Mohr; Karl Heinz Weiss
Journal:  Ann Transl Med       Date:  2019-04

Review 4.  A review and current perspective on Wilson disease.

Authors:  Mallikarjun Patil; Keyur A Sheth; Adarsh C Krishnamurthy; Harshad Devarbhavi
Journal:  J Clin Exp Hepatol       Date:  2013-07-06

5.  Copper accelerates glycolytic flux in cultured astrocytes.

Authors:  Ivo F Scheiber; Ralf Dringen
Journal:  Neurochem Res       Date:  2011-02-13       Impact factor: 3.996

6.  Spontaneous hepatic copper accumulation in Long-Evans Cinnamon rats with hereditary hepatitis. A model of Wilson's disease.

Authors:  Y Li; Y Togashi; S Sato; T Emoto; J H Kang; N Takeichi; H Kobayashi; Y Kojima; Y Une; J Uchino
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

7.  Altered zinc balance in the Atp7b-/- mouse reveals a mechanism of copper toxicity in Wilson disease.

Authors:  Kelsey A Meacham; María Paz Cortés; Eve M Wiggins; Alejandro Maass; Mauricio Latorre; Martina Ralle; Jason L Burkhead
Journal:  Metallomics       Date:  2018-11-14       Impact factor: 4.526

8.  Functional analysis and drug response to zinc and D-penicillamine in stable ATP7B mutant hepatic cell lines.

Authors:  Gursimran Chandhok; Judit Horvath; Annu Aggarwal; Mohit Bhatt; Andree Zibert; Hartmut Hj Schmidt
Journal:  World J Gastroenterol       Date:  2016-04-28       Impact factor: 5.742

9.  Antibacterial and Biocompatible Titanium-Copper Oxide Coating May Be a Potential Strategy to Reduce Periprosthetic Infection: An In Vitro Study.

Authors:  German A Norambuena; Robin Patel; Melissa Karau; Cody C Wyles; Paul J Jannetto; Kevin E Bennet; Arlen D Hanssen; Rafael J Sierra
Journal:  Clin Orthop Relat Res       Date:  2017-03       Impact factor: 4.176

10.  Exogenous copper exposure causing clinical wilson disease in a patient with copper deficiency.

Authors:  Blanca C Lizaola-Mayo; Rolland C Dickson; Dora M Lam-Himlin; David M Chascsa
Journal:  BMC Gastroenterol       Date:  2021-07-08       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.